Cadian Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-140,000
Closed -$16.2M 57
2016
Q4
$16.2M Sell
140,000
-240,000
-63% -$26.7M 0.86% 28
2016
Q3
$39.7M Buy
+380,000
New +$41.1M 2.1% 17
2014
Q3
Sell
-830,000
Closed -$71.3M 98
2014
Q2
$71.3M Buy
830,000
+570,000
+219% +$43.3M 2.12% 14
2014
Q1
$18.1M Sell
260,000
-141,294
-35% -$11.2M 0.45% 42
2013
Q4
$33.9M Buy
401,294
+81,094
+25% +$6.42M 0.87% 27
2013
Q3
$24.7M Buy
+320,200
New +$22.4M 0.72% 31

Other funds holding CELG

Cadian Capital Management's CELG Position: Q1 2017 in Review

Cadian Capital Management sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 140,000 shares — an estimated $16.2M sold.

Cadian Capital Management first reported a position in CELG in Q3 2013 and held it in 6 quarters. The position peaked at $71.3M in Q2 2014. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • Cadian Capital Management reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
  • Cadian Capital Management sold 140,000 Celgene Corp shares in Q1 2017, an estimated $16.2M.
  • Cadian Capital Management first reported a position in Celgene Corp in Q3 2013 and held it in 6 quarters.
  • Cadian Capital Management's Celgene Corp position peaked at $71.3M in Q2 2014.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Cadian Capital Management's 13F filing for Q1 2017, filed 12 May 2017.